D&L’s Expensive Growth

The Philippine specialty manufacturer had a banner year for sales. The harder question is whether those sales can again be converted into cash.

In most years, a 36% jump in revenue would be cause for uncomplicated celebration. At D&L Industries, a Philippine maker of food ingredients, oleochemicals, specialty plastics, and outsourced consumer products, sales rose to ₱55.39bn in 2025, from ₱40.67bn a year earlier. Net income rose too, by 11% to ₱2.59bn. The trouble is that the top line grew much faster than the profit line. Gross profit increased by only 15% to ₱7.21bn, a respectable showing but one that betrayed the nature of the boom: part volume, part pricing, part inflation. D&L sold more, but it also sold costlier molecules.

That makes 2025 a useful year for understanding D&L’s business. The company is not a typical consumer manufacturer with brands on supermarket shelves. It is more often hidden inside other firms’ products: the fat in a noodle, the ingredient in a personal-care formulation, the colorant in a plastic part, the aerosol filled for someone else’s label. Its advantage is technical intimacy. Customers ask for a particular function, mouthfeel, color, viscosity, biodegradability, or cost profile; D&L tries to meet those requirements. The more bespoke the product, the better the margin. 

But 2025 showed the limits of even a clever formulator’s power. Raw materials, especially coconut oil, rose sharply. D&L can usually pass input costs on to customers, but only with a lag of roughly 30 to 45 days. In a gentle commodity cycle, this mechanism works well. In a sudden spike, it becomes a squeeze. Revenue inflates immediately; margins recover later, if at all. That is why gross margin fell to about 13%, from roughly 15% in 2024, even as the company posted record sales. 

The giant that stumbled

The most conspicuous casualty was the food-ingredients division, D&L’s largest business. Through Oleo-Fats and D&L Premium Foods, the group supplies specialty fats, oils, mixes, condiments, and food-safety products to food manufacturers, restaurants, and quick-service chains. In 2025, the segment still enjoyed solid demand: high-margin specialty product volumes rose by 13%. Yet earnings in the division fell 61% year on year, dragged down by the extraordinary rise in coconut-oil prices.

This is the paradox of D&L’s food business. It is large and embedded, but not yet sufficiently insulated from commodity swings. Its customers value customization, consistency, and food-safety support. Still, when raw-material costs lurch upward, the division can resemble a well-run toll road whose asphalt price has suddenly doubled. More vehicles pass through; the owner earns less per vehicle. The company’s medium-term task is therefore plain: reduce the share of low-margin commodity exposure and increase the proportion of customized, higher-margin formulations. 

Chemrez saves the year

If food was the disappointment, Chemrez was the rescue act. The oleochemicals, resins, and powder coatings segment grew volumes by 24%, while net income rose by 96%. Demand for coconut-derived products remained strong, and the Philippine biodiesel mandate increased from B2 to B3 in October 2024, providing an additional domestic tailwind. 

Chemrez is strategically important because it is not merely a biodiesel producer. It also makes higher-value coconut-based chemicals used in personal care, home care, nutrition, and industrial applications. That gives it optionality. If domestic biodiesel demand weakens, management says production can be redirected towards exporting oleochemicals. In a country that produces coconuts but often exports too little sophistication, Chemrez is an example of value added to agricultural feedstock through chemistry, certification, and customer qualification.

Yet this business, too, carries risk. Its raw material is the same coconut complex that is used in squeezed food ingredients. It also benefits from regulation, and regulation can change. A business built on both global specialty demand and domestic mandates is attractive, but not riskless.

Small divisions with large hints

D&L’s smaller divisions tell investors what the company would like to become. Specialty plastics, which make colorants, additive masterbatches, and engineered polymers, produced another good year. Earnings rose 9% in 2025 after a strong 2024, helped by new product development and sustainability-led materials. This is not the largest revenue contributor, but it is a high-quality franchise: more science, less commodity; more formulation, less bulk. 

Consumer Products ODM also staged a recovery. Earnings rose 80%, helped by the ramp-up of the Batangas plant and export growth. The division manufactures aerosols and non-aerosols for other companies, handling formulation, packaging, and production without owning the brands. Exports now contribute meaningfully to the segment, rising from virtually nothing six years ago to 16% of sales.

Together, these units point to the desired shape of D&L’s future: less exposed to domestic commodity pass-through, more reliant on export customers, more reliant on proprietary know-how, and more reliant on high-margin niches.

The Batangas bet

The centerpiece of that future is the Batangas plant. The facility turned profitable in 2024, ahead of the original target, and remained a stable contributor in 2025. Management wants to use it to raise capacity utilization, push exports, and expand higher-margin businesses. The long-term export ambition is bold: to lift exports to 50% of revenue, up from roughly a quarter in 2025. 

The investment logic is sound. Export customers often require scale, traceability, certifications, and supply reliability. A modern plant improves D&L’s ability to win those contracts. It also provides operating leverage: as utilization rises, fixed costs should be spread across more volume. That is the good version of the story.

The less flattering version is that big plants consume capital before they produce cash. D&L is now past peak construction, but the balance sheet still carries the marks of expansion and inflation. Total assets rose to ₱53.01bn, from ₱48.37bn, while current assets rose to ₱32.80bn. Inventories climbed to ₱12.46bn, receivables to ₱8.98bn, and prepayments and other current assets to ₱7.78bn. 

The balance sheet tightens

The liability side grew faster than equity. Total liabilities increased to ₱30.14bn, from ₱26.58bn, while equity rose to ₱22.87bn, from ₱21.79bn. The current ratio slipped to 1.16x, from 1.25x. None of this suggests distress. But it does suggest a business with less room for error than before. 

Debt is the key watch item. Total borrowings and bonds reached ₱25.30bn, up from ₱21.09bn. Net debt rose to ₱21.90bn, and net debt-to-equity increased to 0.96x, from 0.84x. Finance costs jumped 40% to ₱1.36bn, reducing interest cover to around 3x, from 4x. 

For a company with stable demand, long customer relationships, and technical barriers, this leverage is manageable. For a company exposed to raw-material shocks, it is less comfortable. The lesson of 2025 is that D&L can remain profitable during a commodity squeeze. The question is whether it can remain cash-generative.

Profit is not cash

The cash flow statement is the most important part of the annual results. D&L earned ₱2.59bn, but operating cash flow was only about ₱568m. Capital expenditure was roughly ₱849m, leaving free cash flow at about negative ₱281m. After dividends of ₱1.52bn, the company needed financing inflows to keep cash balances rising. 

This does not mean the dividend is immediately unsafe. D&L’s policy is to pay at least half of prior-year recurring income, and the company has a long record of distributions. But 2025’s dividend was covered by accounting earnings, not by free cash flow. That distinction matters. A dividend funded from profits is healthy; a dividend funded from borrowing during a working-capital squeeze is tolerable only if the squeeze reverses.

The company’s cash conversion cycle improved to 110 days from 139 days, but peso working capital still rose due to higher input prices. This is a subtle but important point. Operational efficiency may improve even as cash absorption worsens if the price of what one must hold in inventory rises enough. 

A good business in an expensive year

So what, finally, was 2025? It was not a bad year. D&L grew sales, increased earnings, brought Batangas further into service, expanded exports, and demonstrated Chemrez's strength. It also showed resilience in a difficult commodity environment. 

But it was not an uncomplicatedly good year either. Growth was expensive. Margins compressed. Debt rose. Interest costs climbed. Free cash flow turned negative. The company’s best businesses — oleochemicals, specialty plastics, and ODM exports — showed the direction of travel. Its largest business — food ingredients — showed why that journey matters. 

D&L’s investment case now depends less on its ability to grow revenue. It clearly can. The better questions are whether it can recover gross margins, convert Batangas capacity into higher-value exports, and turn reported earnings back into free cash flow. If it does, 2025 will look like a transition year: messy, inflationary, but ultimately useful. If it does not, investors may conclude that D&L has mastered the art of selling more without yet earning enough more from each sale.

For now, D&L remains a fine Philippine industrial business with a very modern problem. It has demand, customers, technology, and ambition. What it needs next is not merely growth. It needs cheaper growth. 

We’ve been blogging for free. If you enjoy our content, consider supporting us!

Disclaimer: This is for informational purposes and is not investment advice. Figures are taken from company disclosures and exchange data; valuation ratios include the author’s calculations based on cited inputs.